Asymmetric liposomes for the highly efficient encapsulation of nucleic acids and hydrophilic anionic compounds, and method for preparing same
The present invention relates to asymmetric liposomes for high encapsulation efficiency of nucleic acids and hydrophilic anionic compounds, and to a method for preparing same, and specifically, to asymmetric liposomes consisting of a cationic lipid having a small head group as an internal lipid and a neutral or PEGylated lipid having a big head group as an external lipid, wherein nucleic acids and/or anionic compounds are encapsulated in the internal lipid. According to the present invention, asymmetric liposomes, in which nucleic acids and hydrophilic anionic compounds are encapsulated with high efficiency, may be prepared, and thus the same may be used for various purposes, such as gene therapy, and the delivery of hydrophilic anionic drugs which are difficult to prepare as prodrugs, and drug delivery, imaging, etc. can be carried out by encapsulating a fluorescent contrast agent in the liposome.
1. A method of preparing an asymmetric liposome, wherein a nucleic acid and/or a hydrophilic anionic compound are encapsulated in an internal aqueous compartment of the liposome, comprising:
preparing an inner inverted micelle encapsulating the nucleic acid and/or the hydrophilic anionic compound in a cationic lipid and neutral lipid mixture forming an inner layer lipid by use of ether/buffer solution mixture liquid (step 1);
preparing an outer inverted micelle comprising neutral phospholipids, PEGylated phospholipids and cholesterol as an outer layer lipid by use of ether/alcohol/buffer solution mixture liquid (step 2); and
preparing the asymmetric liposome encapsulating therein the nucleic acid and/or the hydrophilic anionic compound by mixing the inner inverted micelle and the outer inverted micelle respectively prepared at steps 1 and 2, evaporating organic solvent, and performing dialysis (step 3);
wherein the inner layer lipid comprises dioleoyl dimethylammonium-propane (DODAP) and dipalmitoylphosphatidyl ethanolamine (DOPE) or dioleoyl phosphatidylethanolamine (DPPE), in a composition ratio of DODAP:DOPE or DPPE=1:1 to 9:1,
wherein the hydrophilic anionic compound is selected from the group consisting of calcein, indocyanine green and combinations thereof;
wherein the neutral phospholipids comprise distearoyl phosphatidylcholine/dioleoyl phosphatidylethanolamine (DSPC/DOPE), dipalmitoylphosphatidyl ethanolamine/dioleoyl phosphatidylethanolamine (DPPE/DOPE) or distearoyl phosphatidylcholine/dipalmitoylphosphatidyl ethanolamine (DSPC/DPPE);
wherein the PEGylated phospholipids comprise polyethyleneglycol-phosphatidylethanolamine (PEG-PE) and functional PEG-PE,
wherein the functional PEG-PE is PEG-PE which is functionalized with a maleimide or a carboxylic group.
2. The method as set forth in claim 1 , wherein the step 1 comprises preparing the inner inverted micelle by suspending the cationic lipid, the neutral lipid and the nucleic acid and/or the hydrophilic anionic compound in a buffer solution pH 4, adding ether and stirring with ultrasonic waves.
3. The method as set forth in claim 1 , wherein at step 1, the ratio of negative ion/positive ion (N/P) of the nucleic acid and the cationic lipid in the preparation of the nucleic acid-encapsulating liposome ranges between 1:2 to 1:10 in molar ratio.
4. The method as set forth in claim 1 , wherein at step 1, the hydrophilic anionic compound and the nucleic acid are encapsulated individually or simultaneously.
5. The method as set forth in claim 1 , wherein step 2 comprises forming the outer inverted micelle by adding the neutral phospholipids, the PEGylated phospholipids and the cholesterol to alcohol and buffer solution and suspending the same, adding ether and stirring with ultrasonic waves.
6. The method as set forth in claim 5 , wherein the alcohol and buffer solution has a ratio of 2:1 to 1:1.
7. The method as set forth in claim 5 , wherein the alcohol is methanol or ethanol.
8. The method as set forth in claim 5 , wherein the molar ratio of the neutral phospholipids to the entire outer layer lipid is equal to or less than 1/2.
9. The method as set forth in claim 5 , wherein the molar ratio of the cholesterol to the entire outer layer lipid is equal to or greater than 1/3.
10. The method as set forth in claim 5 , wherein the molar ratio of the PEG-PE to the entire outer layer lipid ranges between 1/6 to 1/4, wherein the molar ratio of the functional PEG-PE to the entire outer layer lipid is equal to or less than 1/60.
11. The method as set forth in claim 1 , wherein the method further comprises attaching a functional group to a surface of the asymmetric liposome prepared at step 3.